<?xml version='1.0' encoding='UTF-8'?>
<Organism_Record>
  <Organism_ID>ASD11630000_1</Organism_ID>
  <Organism>Human</Organism>
  <Organism_Latin>Homo sapiens</Organism_Latin>
  <UniProt_ID>Q9UM07</UniProt_ID>
  <Seq_Length>663</Seq_Length>
  <Molecule_Weight>74079</Molecule_Weight>
  <KEGG_ID>hsa:23569</KEGG_ID>
  <Orthology_ID>K01481</Orthology_ID>
  <Function_Summary>Catalyzes the citrullination/deimination of arginine residues of proteins such as histones, thereby playing a key role in histone code and regulation of stem cell maintenance. Citrullinates histone H1 at 'Arg-54' (to form H1R54ci), histone H3 at 'Arg-2', 'Arg-8', 'Arg-17' and/or 'Arg-26' (to form H3R2ci, H3R8ci, H3R17ci, H3R26ci, respectively) and histone H4 at 'Arg-3' (to form H4R3ci). Acts as a key regulator of stem cell maintenance by mediating citrullination of histone H1: citrullination of 'Arg-54' of histone H1 (H1R54ci) results in H1 displacement from chromatin and global chromatin decondensation, thereby promoting pluripotency and stem cell maintenance. Promotes profound chromatin decondensation during the innate immune response to infection in neutrophils by mediating formation of H1R54ci. Citrullination of histone H3 prevents their methylation by CARM1 and HRMT1L2/PRMT1 and represses transcription. Citrullinates EP300/P300 at 'Arg-2142', which favors its interaction with NCOA2/GRIP1.</Function_Summary>
  <Catalytic_Mechanism>Protein L-arginine + H(2)O = protein L-citrulline + NH(3).</Catalytic_Mechanism>
  <Pfam_ID>PF03068:PAD@@PF08527:PAD_M@@PF08526:PAD_N</Pfam_ID>
  <Allosteric_Activator_Count>1</Allosteric_Activator_Count>
  <Allosteric_Inhibitor_Count>1</Allosteric_Inhibitor_Count>
  <Allosteric_Regulator_Count>0</Allosteric_Regulator_Count>
  <Alias_List>
      <Alias>Peptidylarginine deiminase IV</Alias>
      <Alias>Protein-arginine deiminase type IV</Alias>
      <Alias>HL-60 PAD</Alias>
  </Alias_List>
  <Function_List>
    <Funtion>
      <Detail>Catalysis of the reaction: L-arginine + H2O = L-citrulline + NH3.</Detail>
      <Keyword>Arginine deiminase activity</Keyword>
      <Ontology_ID>GO:0016990</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with calcium ions (Ca2+).</Detail>
      <Keyword>Calcium ion binding</Keyword>
      <Ontology_ID>GO:0005509</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the hydrolysis of various bonds, e.g. C-O, C-N, C-C, phosphoric anhydride bonds, etc. Hydrolase is the systematic name for any enzyme of EC class 3.</Detail>
      <Keyword>Hydrolase activity</Keyword>
      <Ontology_ID>GO:0016787</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the reaction: protein L-arginine + H2O = protein L-citrulline + NH3.</Detail>
      <Keyword>Protein-arginine deiminase activity</Keyword>
      <Ontology_ID>GO:0004668</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with any metal ion.</Detail>
      <Keyword>Metal ion binding</Keyword>
      <Ontology_ID>GO:0046872</Ontology_ID>
    </Funtion>
  </Function_List>
  <BioProcess_List>
    <BioProcess>
      <Detail>Innate immune responses are defense responses mediated by germline encoded components that directly recognize components of potential pathogens.</Detail>
      <Keyword>Innate immune response</Keyword>
      <Ontology_ID>GO:0045087</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that modulates the frequency, rate or extent of cellular DNA-dependent transcription.</Detail>
      <Keyword>Regulation of transcription, DNA-dependent</Keyword>
      <Ontology_ID>GO:0006355</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Protein involved in immunity, any immune system process that functions in the response of an organism to a potential internal or invasive threat. The vertebrate immune system is formed by the innate immune system (composed of phagocytes, complement, antimicrobial peptides, etc) and by the adaptive immune system which consists of T- and B-lymphocytes.</Detail>
      <Keyword>Immunity</Keyword>
      <Ontology_ID>KW-0391</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that modulates the frequency, rate or extent of the synthesis of either RNA on a template of DNA or DNA on a template of RNA.</Detail>
      <Keyword>Regulation of transcription</Keyword>
      <Ontology_ID>GO:0045449</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The process in which an organism retains a population of stem cells, preventing the commitment of all stem cell progeny to a differentiated cell fate.</Detail>
      <Keyword>Stem cell maintenance</Keyword>
      <Ontology_ID>GO:0019827</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The covalent alteration of one or more amino acids occurring in proteins, peptides and nascent polypeptides (co-translational, post-translational modifications). Includes the modification of charged tRNAs that are destined to occur in a protein (pre-translation modification).</Detail>
      <Keyword>Protein modification process</Keyword>
      <Ontology_ID>GO:0006464</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Dynamic structural changes to eukaryotic chromatin occurring throughout the cell division cycle. These changes range from the local changes necessary for transcriptional regulation to global changes necessary for chromosome segregation.</Detail>
      <Keyword>Chromatin remodeling</Keyword>
      <Ontology_ID>GO:0006338</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The cellular synthesis of RNA on a template of DNA.</Detail>
      <Keyword>Transcription, DNA-dependent</Keyword>
      <Ontology_ID>GO:0006351</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The alteration of DNA or protein in chromatin, which may result in changing the chromatin structure.</Detail>
      <Keyword>Chromatin modification</Keyword>
      <Ontology_ID>GO:0016568</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The hydrolysis of peptidyl-arginine to form peptidyl-citrulline.</Detail>
      <Keyword>Peptidyl-citrulline biosynthetic process from peptidyl-arginine</Keyword>
      <Ontology_ID>GO:0018101</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The cellular synthesis of either RNA on a template of DNA or DNA on a template of RNA.</Detail>
      <Keyword>Transcription</Keyword>
      <Ontology_ID>GO:0006350</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The aggregation, arrangement and bonding together of a nucleosome, the beadlike structural units of eukaryotic chromatin composed of histones and DNA.</Detail>
      <Keyword>Nucleosome assembly</Keyword>
      <Ontology_ID>GO:0006334</Ontology_ID>
    </BioProcess>
  </BioProcess_List>
  <PTM_List>
    <PTM>
      <Position>383</Position>
      <PTM_Type>Citrulline</PTM_Type>
    </PTM>
    <PTM>
      <Position>218</Position>
      <PTM_Type>Citrulline</PTM_Type>
    </PTM>
    <PTM>
      <Position>205</Position>
      <PTM_Type>Citrulline</PTM_Type>
    </PTM>
    <PTM>
      <Position>374</Position>
      <PTM_Type>Citrulline</PTM_Type>
    </PTM>
    <PTM>
      <Position>212</Position>
      <PTM_Type>Citrulline</PTM_Type>
    </PTM>
    <PTM>
      <Position>372</Position>
      <PTM_Type>Citrulline</PTM_Type>
    </PTM>
  </PTM_List>
  <Molecule_Seq>
    <Protein_Seq>MAQGTLIRVTPEQPTHAVCVLGTLTQLDICSSAPEDCTSFSINASPGVVVDIAHGPPAKKKSTGSSTWPLDPGVEVTLTMKVASGSTGDQKVQISYYGPKTPPVKALLYLTGVEISLCADITRTGKVKPTRAVKDQRTWTWGPCGQGAILLVNCDRDNLESSAMDCEDDEVLDSEDLQDMSLMTLSTKTPKDFFTNHTLVLHVARSEMDKVRVFQATRGKLSSKCSVVLGPKWPSHYLMVPGGKHNMDFYVEALAFPDTDFPGLITLTISLLDTSNLELPEAVVFQDSVVFRVAPWIMTPNTQPPQEVYACSIFENEDFLKSVTTLAMKAKCKLTICPEEENMDDQWMQDEMEIGYIQAPHKTLPVVFDSPRNRGLKEFPIKRVMGPDFGYVTRGPQTGGISGLDSFGNLEVSPPVTVRGKEYPLGRILFGDSCYPSNDSRQMHQALQDFLSAQQVQAPVKLYSDWLSVGHVDEFLSFVPAPDRKGFRLLLASPRSCYKLFQEQQNEGHGEALLFEGIKKKKQQKIKNILSNKTLREHNSFVERCIDWNRELLKRELGLAESDIIDIPQLFKLKEFSKAEAFFPNMVNMLVLGKHLGIPKPFGPVINGRCCLEEKVCSLLEPLGLQCTFINDFFTYHIRHGEVHCGTNVRRKPFSFKWWNMVP</Protein_Seq>
  </Molecule_Seq>
  <CellLocal_List>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Cytoplasmic granule</CellLocal>
      <Ontology_ID>SwissProt</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Nucleus</CellLocal>
      <Ontology_ID>GO:0005634</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Cytoplasm</CellLocal>
      <Ontology_ID>GO:0005737</Ontology_ID>
    </AsdMacromoleculeCelllocal>
  </CellLocal_List>
  <Gene>
    <Gene_Name>PADI4</Gene_Name>
    <Gene_Alias>PADI5; PDI5</Gene_Alias>
    <Gene_ID>23569</Gene_ID>
    <Genbank_ACCN>NM_012387</Genbank_ACCN>
    <Protein_ACCN>NP_036519</Protein_ACCN>
    <HGNC_ID>18368</HGNC_ID>
    <Gene_URL>http://www.ncbi.nlm.nih.gov/gene/23569</Gene_URL>
    <UCSC_ID>uc001baj.2</UCSC_ID>
    <EMBL_ID>ENSG00000159339</EMBL_ID>
  </Gene>
  <Disease_List>
    <Disease>
      <Disease_Name>Rheumatoid Arthritis</Disease_Name>
      <Disease_Detail>Rheumatoid Arthritis</Disease_Detail>
      <Disease_DB>RHM011</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/rheumatoid_arthritis?search=PADI4#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Palindromic Rheumatism</Disease_Name>
      <Disease_Detail>Palindromic Rheumatism</Disease_Detail>
      <Disease_DB>PLN005</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/palindromic_rheumatism?search=PADI4#related_genes</Disease_URL>
    </Disease>
  </Disease_List>
  <PDB_List>
    <PDB>
      <PDB_Title>Crystal structure of human peptidylarginine deiminase 4 in complex with o-Cl-amidine</PDB_Title>
      <PDB_ID>3B1T</PDB_ID>
      <Resolution>2.5</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3B1T</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD11630001</ASD_Ligand>
      <PubMed_Title>The Development of N-alpha-(2-Carboxyl)benzoyl-N(5)-(2-fluoro-1-iminoethyl)-l-ornithine Amide (o-F-amidine) and N-alpha-(2-Carboxyl)benzoyl-N(5)-(2-chloro-1-iminoethyl)-l-ornithine Amide (o-Cl-amidine) As Second Generation Protein Arginine Deiminase (PAD) Inhibitors</PubMed_Title>
      <Author>Causey, C.P., et al.</Author>
      <Journal>J.Med.Chem.(2011)54:6919-6935</Journal>
      <PubMed_ID>21882827</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of human peptidylarginine deiminase type4 (PAD4) in complex with benzoyl-L-arginine amide</PDB_Title>
      <PDB_ID>1WDA</PDB_ID>
      <Resolution>2.3</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1WDA</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD11630001</ASD_Ligand>
      <PubMed_Title>Structural basis for Ca(2+)-induced activation of human PAD4</PubMed_Title>
      <Author>Arita, K., et al.</Author>
      <Journal>Nat.Struct.Mol.Biol.(2004)11:777-783</Journal>
      <PubMed_ID>15247907</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of human peptidylarginine deiminase 4 in complex with histone H3 N-terminal peptide including Arg17</PDB_Title>
      <PDB_ID>2DEX</PDB_ID>
      <Resolution>2.1</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2DEX</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD11630001</ASD_Ligand>
      <PubMed_Title>Structural basis for histone N-terminal recognition by human peptidylarginine deiminase 4</PubMed_Title>
      <Author>Arita, K., et al.</Author>
      <Journal>Proc.Natl.Acad.Sci.Usa(2006)103:5291-5296</Journal>
      <PubMed_ID>16567635</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Calcium bound form of human peptidylarginine deiminase type4 (PAD4)</PDB_Title>
      <PDB_ID>1WD9</PDB_ID>
      <Resolution>2.6</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1WD9</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD11630001</ASD_Ligand>
      <PubMed_Title>Structural basis for Ca(2+)-induced activation of human PAD4</PubMed_Title>
      <Author>Arita, K., et al.</Author>
      <Journal>Nat.Struct.Mol.Biol.(2004)11:777-783</Journal>
      <PubMed_ID>15247907</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Calcium free form of human peptidylarginine deiminase type4 (PAD4)</PDB_Title>
      <PDB_ID>1WD8</PDB_ID>
      <Resolution>2.8</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1WD8</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structural basis for Ca(2+)-induced activation of human PAD4</PubMed_Title>
      <Author>Arita, K., et al.</Author>
      <Journal>Nat.Struct.Mol.Biol.(2004)11:777-783</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/15247907?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of human peptidylarginine deiminase 4 in complex with o-F-amidine</PDB_Title>
      <PDB_ID>3B1U</PDB_ID>
      <Resolution>2.1</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3B1U</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD11630001</ASD_Ligand>
      <PubMed_Title>The Development of N-alpha-(2-Carboxyl)benzoyl-N(5)-(2-fluoro-1-iminoethyl)-l-ornithine Amide (o-F-amidine) and N-alpha-(2-Carboxyl)benzoyl-N(5)-(2-chloro-1-iminoethyl)-l-ornithine Amide (o-Cl-amidine) As Second Generation Protein Arginine Deiminase (PAD) Inhibitors</PubMed_Title>
      <Author>Causey, C.P., et al.</Author>
      <Journal>J.Med.Chem.(2011)54:6919-6935</Journal>
      <PubMed_ID>21882827</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of human peptidylarginine deiminase 4 in complex with N-alpha-benzoyl-N5-(2-fluoro-1-iminoethyl)-L-ornithine amide</PDB_Title>
      <PDB_ID>2DW5</PDB_ID>
      <Resolution>2.3</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2DW5</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD11630001</ASD_Ligand>
      <PubMed_Title>Inhibitors and Inactivators of Protein Arginine Deiminase 4: Functional and Structural Characterization</PubMed_Title>
      <Author>Luo, Y., et al.</Author>
      <Journal>Biochemistry(2006)45:11727-11736</Journal>
      <PubMed_ID>17002273</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of human peptidylarginine deiminase 4 in complex with N-acetyl-L-threonyl-L-alpha-aspartyl-N5-[(1E)-2-fluoroethanimidoyl]-L-ornithinamide</PDB_Title>
      <PDB_ID>4DKT</PDB_ID>
      <Resolution>2.98</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4DKT</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD11630001</ASD_Ligand>
      <PubMed_Title>Synthesis and Screening of a Haloacetamidine Containing Library To Identify PAD4 Selective Inhibitors.</PubMed_Title>
      <Author>Jones, J.E., et al.</Author>
      <Journal>Acs Chem.Biol.(2012)7:160-165</Journal>
      <PubMed_ID>22004374</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of the human SNP PAD4 protein</PDB_Title>
      <PDB_ID>3APM</PDB_ID>
      <Resolution>2.5</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3APM</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structural and biochemical analyses of the human PAD4 variant encoded by a functional haplotype gene</PubMed_Title>
      <Author>Horikoshi, N., et al.</Author>
      <Journal>Acta Crystallogr.,Sect.D(2011)67:112-118</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/21245532?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of human peptidylarginine deiminase 4 in complex with histone H3 N-terminal tail including Arg8</PDB_Title>
      <PDB_ID>2DEW</PDB_ID>
      <Resolution>2.1</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2DEW</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD11630001</ASD_Ligand>
      <PubMed_Title>Structural basis for histone N-terminal recognition by human peptidylarginine deiminase 4</PubMed_Title>
      <Author>Arita, K., et al.</Author>
      <Journal>Proc.Natl.Acad.Sci.Usa(2006)103:5291-5296</Journal>
      <PubMed_ID>16567635</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of human peptidylarginine deiminase 4 in complex with histone H4 N-terminal tail including Arg3</PDB_Title>
      <PDB_ID>2DEY</PDB_ID>
      <Resolution>2.25</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2DEY</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD11630001</ASD_Ligand>
      <PubMed_Title>Structural basis for histone N-terminal recognition by human peptidylarginine deiminase 4</PubMed_Title>
      <Author>Arita, K., et al.</Author>
      <Journal>Proc.Natl.Acad.Sci.Usa(2006)103:5291-5296</Journal>
      <PubMed_ID>16567635</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of the human wild-type PAD4 protein</PDB_Title>
      <PDB_ID>3APN</PDB_ID>
      <Resolution>2.7</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3APN</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structural and biochemical analyses of the human PAD4 variant encoded by a functional haplotype gene</PubMed_Title>
      <Author>Horikoshi, N., et al.</Author>
      <Journal>Acta Crystallogr.,Sect.D(2011)67:112-118</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/21245532?dopt=Abstract</PubMed_ID>
    </PDB>
  </PDB_List>
  <Fold>
    <SCOP_Class>All beta proteins</SCOP_Class>
    <SCOP_URL>http://scop.mrc-lmb.cam.ac.uk/scop/data/scop.b.c.c.j.b.b.html</SCOP_URL>
    <CATH_Class>Class 2: Mainly Beta </CATH_Class>
    <CATH_URL>http://www.cathdb.info/pdb/1wd8</CATH_URL>
  </Fold>
  <AllostericSite_List>
    <AllostericSite>
      <PDB_ID>1WD9;1WDA;2DEW;2DEX;2DEY;2DW5;3B1T;3B1U;4DKT</PDB_ID>
    </AllostericSite>
  </AllostericSite_List>
  <Enzyme_Nomenclature_List>
    <Enzyme_Nomenclature>
      <Enzyme_DB_ID>3.5.3.15</Enzyme_DB_ID>
      <Enzyme_DB_URL>http://www.chem.qmul.ac.uk/iubmb/enzyme/EC3/5/3/15.html</Enzyme_DB_URL>
    </Enzyme_Nomenclature>
  </Enzyme_Nomenclature_List>
  <Modulator_List>
    <Modulator>
      <ASD_ID>ASD11630001</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD11630002</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
  </Modulator_List>
  <Create_Date>2015-04-08</Create_Date>
</Organism_Record>